Stem cells: Self-renewal writ in blood

Dick, John E.
May 2003
Nature;5/15/2003, Vol. 423 Issue 6937, p231
Academic Journal
Summarizes research on a gene regulator that governs the self-renewal of hematopoietic stem cells (HSC) and leukemic stem cells. Cell multiplication induced by the overexpression of a gene transcription factor in HSC; Mutations required to generate leukemic cells.


Related Articles

  • AC133 expression in human stem cells. Bhatia, M // Leukemia (08876924);Nov2001, Vol. 15 Issue 11, p1685 

    Expression of cell surface markers on human hematopoietic cells has provided a method for characterizing subsets of cells with distinct biological functions. This is largely due to the ability to separate highly purified subpopulations of cells for comparative analysis. Relationships between the...

  • Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Mikkola, Hanna K. A.; Klintman, Jenny; Yang, Haidi; Hock, Hanno; Schlaeger, Thorsten M.; Fujiwara, Yuko; Orkin, Stuart H. // Nature;1/30/2003, Vol. 421 Issue 6922, p547 

    The production of blood cells is sustained throughout the lifetime of an individual by haematopoietic stem cells (HSCs). Specification of HSCs from mesoderm during embryonic development requires the stem cell leukaemia SCL/tal-1 gene product. Forced expression of SCL/tal-1 strongly induces blood...

  • CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Burger, J A; Peled, A // Leukemia (08876924);Jan2009, Vol. 23 Issue 1, p43 

    Hematopoietic and epithelial cancer cells express CXCR4, a seven-transmembrane G-protein-coupled chemokine receptor. Stromal cells within the bone marrow microenvironment constitutively secrete stromal cell-derived factor-1 (SDF-1/CXCL12), the ligand for CXCR4. Activation of CXCR4 induces...

  • Targeting Leukemia Stem Cells. Hampton, Tracy // JAMA: Journal of the American Medical Association;6/5/2013, Vol. 309 Issue 21, p2205 

    The article reports the identification on a new compound called RK-20449 by researchers of Japan and the U.S. that is found to inhibit hematopoietic cell kinase, a molecule critical to leukemia stem cells.

  • Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML. Heinzinger, M; Waller, C F; Rosenstiel, A; Scheid, S; Burger, K J; Lange, W // Leukemia (08876924);Mar98, Vol. 12 Issue 3, p333 

    Coexistence of Philadelphia chromosome (Ph)-negative, primitive hematopoietic progenitor cells with their malignant counterparts in chronic myelogenous leukemia (CML) has been reported. As most of the Ph-negative progenitor cells do not express the HLA-DR antigen, selection of them might be...

  • Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia. Guyotat, D; Wahbi, K; Viallet, A; Piselli, S; Campos, L // Leukemia (08876924);Jul99, Vol. 13 Issue 7, p991 

    Philadelphia (Ph) or BCR/ABL-negative cells with immature phenotype (CD34-positive, DR-negative) can be recovered from patients with chronic myeloid leukemia (CML) in chronic phase. We used the technique described by Berardi et al (Science 1995; 267: 104-108) to select stem cells from marrow or...

  • Mechanisms controlling pathogenesis and survival of leukemic stem cells. Jordan, Craig T.; Guzman, Monica L. // Oncogene;9/20/2004 Review, Vol. 23 Issue 43, p7178 

    Stem cells are an integral component of normal mammalian physiology and have been intensively studied in many systems. Intriguingly, substantial evidence indicates that stem cells also play an important role in the initiation and pathogenesis of at least some cancers. In particular, myeloid...

  • A special case of acute leukemia in childhood. Bleahu, Ion Dorin; Vladasel, Roxana; Gheorghe, Anca // Journal of Medicine & Life;Jul-Sep2011, Vol. 4 Issue 3, p297 

    Hybrid leukemia is a clinical entity that includes: biphenotypic leukemia, characterized by the presence of markers of more than two lineages of a single tumor cell, bilineage leukemia, a combination of more than two lineage markers on two distinct blast cells, and biclonal leukemia, the...

  • Emerging Stem Cell Therapies: Treatment, Safety, and Biology. Joel Sng; Thomas Lufkin // Stem Cells International;2012, p1 

    Stem cells are the fundamental building blocks of life and contribute to the genesis and development of all higher organisms. The discovery of adult stem cells has led to an ongoing revolution of therapeutic and regenerative medicine and the proposal of novel therapies for previously terminal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics